Ashford Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,483
| Closed | -$1.56M | – | 108 |
|
|
2024
Q3 | $1.56M | Sell |
1,483
-89
| -6% | -$93.6K | 0.19% | 70 |
|
|
2024
Q2 | $1.65M | Hold |
1,572
| – | – | 0.22% | 66 |
|
|
2024
Q1 | $1.51M | Sell |
1,572
-58
| -4% | -$55.8K | 0.2% | 64 |
|
|
2023
Q4 | $1.43M | Buy |
1,630
+909
| +126% | +$798K | 0.19% | 68 |
|
|
2023
Q3 | $593K | Hold |
721
| – | – | 0.09% | 76 |
|
|
2023
Q2 | $518K | Hold |
721
| – | – | 0.07% | 72 |
|
|
2023
Q1 | $592K | Hold |
721
| – | – | 0.09% | 71 |
|
|
2022
Q4 | $520K | Hold |
721
| – | – | 0.08% | 73 |
|
|
2022
Q3 | $497K | Sell |
721
-135
| -16% | -$93.1K | 0.08% | 79 |
|
|
2022
Q2 | $506K | Hold |
856
| – | – | 0.07% | 78 |
|
|
2022
Q1 | $598K | Hold |
856
| – | – | 0.06% | 85 |
|
|
2021
Q4 | $541K | Sell |
856
-122
| -12% | -$77.1K | 0.05% | 87 |
|
|
2021
Q3 | $592K | Hold |
978
| – | – | 0.05% | 87 |
|
|
2021
Q2 | $546K | Hold |
978
| – | – | 0.05% | 91 |
|
|
2021
Q1 | $463K | Sell |
978
-1,506
| -61% | -$713K | 0.04% | 90 |
|
|
2020
Q4 | $1.2M | Sell |
2,484
-506
| -17% | -$244K | 0.12% | 70 |
|
|
2020
Q3 | $1.67M | Buy |
2,990
+426
| +17% | +$239K | 0.2% | 55 |
|
|
2020
Q2 | $1.6M | Buy |
2,564
+1,534
| +149% | +$957K | 0.21% | 57 |
|
|
2020
Q1 | $503K | Buy |
+1,030
| New | +$503K | 0.09% | 72 |
|